bariatric surgery glp 1 GLP-1 Drugs vs. Interest in Treatment with GLP-1

National Taiwan University researchers highlight the benefits of GLP-1 receptor agonists (GLP-1 RAs) in reducing mortality and severe cardiovascular and renal outcomes for diabetic patients with acute kidney disease (AKD)

In collaboration with Novo Nordisk, Hims & Hers soon will offer access to the only FDA-approved GLP-1 weight loss pill, alongside injectable Wegovy in all dosages

Between 30 million and 50 million US adults could be taking a GLP-1 by 2034. In December 2024, 1.9 million prescriptions of GLP-1s to treat obesity (as opposed to diabetes, for example) were filled, nearly quadruple the number YoY, per IQVIA

The once-daily pill offers new oral cardiovascular risk-reduction option for plan members with diabetes

Obesity and type 2 diabetes (T2D) are associated with increased rates of mental disorders, particularly depression, anxiety and binge-eating disorder

Remedy Meds helps patients achieve weight loss goals primarily through GLP-1 medication like semaglutide and tirzepatide.